Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUS-guided CGN vs Percutaneous CPN for Pancreatic Cancer Pain
NCT02356640Phase 3Terminated
- Sponsor
- The Chinese University of Hong Kong
- Start
- Aug 2014
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in abdominal pain and pancreatic cancer (PC), sponsored by The Chinese University of Hong Kong. Primary endpoint: Visual Analogue Scale at 2 weeks. Started Aug 2014; status: terminated.
02
Conditions
abdominal painpancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02356640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02356640.